EUCTR2020-001026-62-ES进行中（未招募）1 期
Benefits of inhalation of 7% hypertonic saline solution prior to ELTGOL physiotherapy, in patients with bronchiectasis. A randomized controlled trial.
niversity Hospital Dr Josep Trueta0 个研究点目标入组 57 人开始时间: 2021年10月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 57
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men and woman,= 18 years old with bronchiectasis confirmed by high resolution computed tomography, with no exacerbations in the previous month, chronic purulent sputum (=10ml daily expectoration), at least one exacerbation in the previous year, FEV1 =30% after bronchodilation and sign the informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 32
排除标准
- •=85 years old,asthma, allergic bronchopulmonary aspergillosis or CF; current smokers or a smoking history of =20 p-y; following mucoactive treatment in the month previous; contraindications to perform ELTGOL, spirometry or to attend visits; practising pulmonary rehabilitation in the previous 6 months, change of treatment the previous month; uncontrolled hypertension
研究者
相似试验
尚未招募
3 期
Effect of 7% hypertonic saline in bronchiolitisCTRI/2022/12/048606ONE
进行中（未招募）
不适用
The effect of inhalation with hypertonic saline (7%) on lung function and sputum rheology in Cystic Fibrosis patientsMucoviscidoseMedDRA version: 9.1Level: LLTClassification code 10011763Term: Cystic fibrosis lungEUCTR2007-002707-40-BEniversity Hospital Ghent60
已完成
不适用
Effects of inhaled hypertonic saline in children with cystic fibrosisCystic fibrosisGenetic DiseasesISRCTN13412080Sapienza University of Rome12
已完成
3 期
Does Nebulized 3% Hypertonic Saline Shorten the Duration of Hospitalization in Preschool Children with Acute Wheezing?preschool wheezinghypertonic salinelength of stayrandomized controlled trialTCTR20170327001none50
已完成
3 期
The long term effect of inhaled hypertonic saline (6%) in non-cystic fibrosis bronchiectasis.on-cystic fibrosis bronchiechtasisNon-cystic fibrosis bronchiechtasisRespiratory - Other respiratory disorders / diseasesACTRN12607000367448Alfred Hospital, Physiotherapy Department40